JPL Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
JPL Wealth Management's PFE Position: Q1 2026 in Review
JPL Wealth Management increased its Pfizer (PFE) stake by 15% in Q1 2026, buying an estimated $43.4K and bringing the position to 12,405 shares worth $348K. The position accounts for 0.08% of the portfolio, ranked #102.
JPL Wealth Management first reported a position in PFE in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.14M in Q4 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- JPL Wealth Management held 12,405 shares of Pfizer worth $348K as of Q1 2026.
- JPL Wealth Management bought 1,632 Pfizer shares in Q1 2026, an estimated $43.4K.
- Pfizer made up 0.08% of JPL Wealth Management's portfolio in Q1 2026, its #102 holding.
- JPL Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 7 quarters since.
- JPL Wealth Management's Pfizer position peaked at $1.14M in Q4 2023.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.